AMBRIDGE, Mass.--(BUSINESS WIRE)--June 14, 2006--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY - News), a leading RNAi therapeutics company, announced today the appointment of Saraswathy (Sara) Nochur, Ph.D., to the position of Vice President, Regulatory Affairs. Dr. Nochur has extensive industry experience in the areas of regulatory affairs and overall drug development. At Alnylam, she will be responsible for leading the global regulatory strategy for the company's development-stage programs and overseeing regulatory operations, and will be a member of the management team.
